EXPERT OPIN INV DRUG 潤色咨詢

EXPERT OPINION ON INVESTIGATIONAL DRUGS

出版年份:1994 年文章數(shù):1043 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:Monthly 自引率:2.5% 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費用
暫無數(shù)據(jù)
版面費用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量11.54% (2022年為9.80%)
自引率
2.5 %
年文章數(shù)
1043
期刊官網(wǎng)
點擊查看 (點擊次數(shù):8007)
投稿鏈接
點擊查看 (點擊次數(shù):1991次)
作者需知
暫無數(shù)據(jù)
偏重的研究方向
期刊簡介
稿件收錄要求
Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1354-3784.

Expert Opinion on Investigational Drugs (EOID) is a monthly peer-reviewed journal, evaluating developments in pharmaceutical research, from animal studies through to the launch of a new medicine. Authors are encouraged to express their Expert Opinion of the status of the research under review, rather than simply reviewing the available data. Each issue of the journal also contains Editorials, Drug Evaluations, Clinical Trial Reports, Meeting Highlights and Paper Evaluations. The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, and many biotechnology companies. Expert Opinion on Investigational Drugs adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.